Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
A new clinical delivery model offers resources to help health care providers, or HCPs, become more culturally competent and improve health outcomes for their Black patients, an expert said.BlackDoctor ...
With pressure from global competitors and recent changes in domestic policy threatening to undermine U.S. leadership in this ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsDavid Hallal - ...
Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.
UCSF received $824 million from the National Institutes of Health (NIH) in 2025 to drive the discovery, translational, and clinical science that leads to new treatments for disease and advances U.S.
In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
Two researchers describe their experiences working on a multidisciplinary team during the development and implementation of an intervention designed to reduce intimate partner violence.
A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...
Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...
Researchers at Fred Hutch Cancer Center are testing whether a collaborative AI research platform can accelerate the pace of ...
New infrastructure strengthens Africa-based clinical trial logistics, reducing costs and accelerating timelines for ...